STOCK TITAN

MOHO - MOHO STOCK NEWS

Welcome to our dedicated page for MOHO news (Ticker: MOHO), a resource for investors and traders seeking the latest updates and insights on MOHO stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect MOHO's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of MOHO's position in the market.

Rhea-AI Summary

On March 16, 2022, ECMOHO Limited (Nasdaq: MOHO) received Nasdaq's approval to transfer its American Depositary Shares (ADSs) listing from the Nasdaq Global Market to the Nasdaq Capital Market. This transfer, effective March 17, 2022, is a response to the company not complying with Nasdaq Listing Rule 5450(a)(1) due to a closing bid price below $1.00 for 30 consecutive business days. The transfer grants ECMOHO an additional 180 days to regain compliance, requiring the ADSs to exceed $1.00 for 10 consecutive days by September 12, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

ECMOHO Limited (Nasdaq: MOHO) announced an increase in its digital marketing efforts to enhance brand presence and customer loyalty in China’s health and wellness market. The company has partnered with Vitamin World to market its health products on major e-commerce platforms like JD and Tmall, aiming to cater to local consumer needs. This collaboration is expected to leverage Vitamin World’s established reputation and product range. CEO Zoe Wang emphasized the commitment to refining operations and expanding premium product offerings, paving the way for enhanced consumer insights and integrated health solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

On December 1, 2021, ECMOHO Limited (Nasdaq: MOHO) announced a change in its Board of Directors. Mr. Greg Ye resigned as an independent director, along with his roles as chair and member of the audit committee. He left for personal reasons, with no disagreement with the company. Mr. Yuan Fang was appointed to the Board, taking on similar roles. Mr. Fang brings over 10 years of experience in venture capital and investment banking. Chairwoman Zoe Wang expressed confidence in Mr. Fang's capabilities to enhance operational efficiency and governance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
Rhea-AI Summary

ECMOHO Limited (Nasdaq: MOHO) reported a significant decline in third-quarter 2021 revenues of US$28.3 million, down from US$71.5 million year-over-year. This drop was attributed to a decrease in product sales, specifically in the mother and child care category, and a strategic shift to partner with brands that offer higher profit margins. Despite this, the company saw improvements in gross margin, rising to 22.7% from 17.7% in Q3 2020. Key operational metrics included a growth in paying consumers to 12.3 million and a repeat purchase rate increase to 38.5%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

ECMOHO Limited (Nasdaq: MOHO) has partnered with Bausch + Lomb to promote and sell vision care products on Pinduoduo, a major Chinese e-commerce platform. This collaboration aims to meet the increasing demand for eye health solutions among Chinese families. Bausch + Lomb, a leader in eye care for over 160 years, is known for setting quality standards in the industry. The agreement is expected to enhance brand visibility and product accessibility in China, leveraging ECMOHO's expertise in health-related marketing and distribution.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
-
Rhea-AI Summary

ECMOHO Limited (Nasdaq: MOHO) received a notification from Nasdaq on September 16, 2021, indicating non-compliance with the minimum bid price requirement, as its closing bid price has been below $1.00 for 30 consecutive business days. The company has a compliance period of 180 days, until March 15, 2022, to regain compliance. If the bid price reaches $1.00 for at least 10 consecutive business days during this period, the issue will be resolved. If not, the company may request an additional 180-day compliance period if it meets other listing requirements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

ECMOHO Limited (MOHO) reported its Q2 2021 results, showing a total net revenue of US$42.8 million, down from US$100.5 million in Q2 2020. Product sales were US$42.1 million, impacted by brand optimization strategies. Gross margin improved to 19.6% from 17.2%, while net loss decreased to US$3.6 million from US$4.5 million last year. The Company successfully raised US$9.0 million in a public offering to boost operational capabilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Aegis Capital Corp. has successfully acted as Sole Bookrunner on a $9 Million Follow-On Offering of American Depositary Shares for ECMOHO Limited (NASDAQ:MOHO). ECMOHO operates in the health and wellness market in China, providing a range of health supplements, nutrition, personal care, and household healthcare products. With over ten years of experience, the company aims to connect health-conscious consumers with trusted global brands, enhancing health regeneration and longevity through its curated offerings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

ECMOHO Limited (Nasdaq: MOHO) has successfully closed a public offering of 10 million American Depositary Shares (ADSs) at $0.90 each, generating $9 million in gross proceeds. The funds will be allocated to investments in the Company's SaaS platform, working capital, and general corporate purposes. The underwriter has a 45-day option to purchase an additional 12.8% of shares, potentially increasing gross proceeds to approximately $10.2 million. This offering is part of a shelf registration statement filed with the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary

ECMOHO Limited (Nasdaq: MOHO) has announced a public offering of 10 million American Depositary Shares (ADSs) priced at $0.90 each, aiming for gross proceeds of $9 million. The funds will support investments in its SaaS platform and general corporate needs. The company has granted an underwriter a 45-day option to purchase an additional 12.8% of ADSs, potentially raising total proceeds to $10.2 million. The offering is expected to close on August 5, 2021, subject to customary conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags

FAQ

What is the market cap of MOHO (MOHO)?

The market cap of MOHO (MOHO) is approximately 4.9M.

MOHO

Nasdaq:MOHO

MOHO Rankings

MOHO Stock Data

4.94M
Link
China (Mainland)
Shanghai